“Efficacy and Safety Profile of Extended Release Tolterodine in Symptomatic Overactive Bladder”, Chatt Maa Shi Hosp Med Coll J, vol. 17, no. 1, pp. 34–37, Dec. 2018, doi: 10.3329/cmoshmcj.v17i1.39440.